Table 2.
Frequency of hepatobiliary manifestations and concomitant liver disease in UC and CD patients.
| Hepatobiliary manifestations | Ulcerative colitis N=165 |
Crohn's disease N=141 |
Total N =306 |
|---|---|---|---|
| Steatosis/steatohepatitis, n (%) | 11 (6.7) | 11 (7.8) | 22 (7.2) |
| Cholelithiasis, n (%) | 9 (5.5) | 11 (7.8) | 20 (6.5) |
| PSC, n (%) | 6 (3.6) | 4 (2.8) | 10 (3.3) |
| Drug hepatotoxicity,∗ n (%) | 3 (1.8) | 3 (2.1) | 6 (2.0) |
| Hepatitis B, n (%) | 1 (0.6) | 1 (0.7) | 1 (0.7) |
| Hepatitis C, n (%) | 1 (0.6) | 1 (0.7) | 2 (0.7) |
| Hepatic fibrosis, n (%) | 0.6(1) | - | 1 (0.3) |
| HAI, n (%) | - | 1 (0.7) | 1 (0.3) |
| Alcoholic liver disease, n (%) | - | 1 (0.7) | 1 (0.3) |
PSC: Primary sclerosing cholangitis; HAI: Autoimmune hepatitis.
Note: In some cases, the same patient presented with more than one manifestation.